Mutated SON putatively causes a cancer syndrome comprising high-risk medulloblastoma combined with café-au-lait spots
Medulloblastoma is the most frequent malignant brain tumor in childhood. This highly malignant neoplasm occurs usually before 10 years of age and more frequently in boys. The 5-year event-free survival rate for high-risk medulloblastoma is low at 62% despite a multimodal therapy including surgical r...
Gespeichert in:
Veröffentlicht in: | Familial cancer 2019-07, Vol.18 (3), p.353-358 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 358 |
---|---|
container_issue | 3 |
container_start_page | 353 |
container_title | Familial cancer |
container_volume | 18 |
creator | Chiu, Celine Loth, Stefanie Kuhlen, Michaela Ginzel, Sebastian Schaper, Jörg Rosenbaum, Thorsten Pietsch, Torsten Borkhardt, Arndt Hoell, Jessica I. |
description | Medulloblastoma is the most frequent malignant brain tumor in childhood. This highly malignant neoplasm occurs usually before 10 years of age and more frequently in boys. The 5-year event-free survival rate for high-risk medulloblastoma is low at 62% despite a multimodal therapy including surgical resection, radiation therapy and chemotherapy. We report the case of a boy, who was born to consanguineous parents. Prominently, he had multiple café-au-lait spots. At the age of 3 years he was diagnosed with a high-risk metastatic medulloblastoma. The patient died only 11 months after diagnosis of a fulminant relapse presenting as meningeal and spinal dissemination. Whole-exome sequencing of germline DNA was employed to detect the underlying mutation for this putative cancer syndrome presenting with the combination of medulloblastoma and skin alterations. After screening all possible homozygous gene SNVs, we identified a mutation of
SON
, an essential protein in cell cycle regulation and cell proliferation, as the most likely genetic cause. |
doi_str_mv | 10.1007/s10689-019-00121-z |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2179423828</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2170788906</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-29ca982cab57b685d3c833c12cff170ecdfdf077b84fde46b7e8a03fe15802a73</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS0Eoj_wAiyQJTZsDNf2JHaWqAKKVNoFsLYcx55JSeLBNymavhHPwYv1DlNAYsHC8pHud46texh7JuGVBDCvUUJtGwGSDkglxe0Ddiwro4VRjXpIWtO4qQGO2AniNYACpc1jdqTJCCsDx-zm4zL7OXb809Ul3-51fxOHHQ9-wYjck5hCLBx3U1fyGHnI47b02E9rvunXG0H6Kx9jtwxDbgePcx79Hmr7iVK_9_OGItLPH8IvYvD9zHGbZ3zCHiU_YHx6f5-yL-_efj47FxdX7z-cvbkQQZtqFqoJvrEq-LYybW2rTgerdZAqpCQNxNClLoExrV2lLq7q1kTrQacoKwvKG33KXh5ytyV_WyLObuwxxGHwU8wLOiVNs1LaKkvoi3_Q67yUiX63p8BY20BNlDpQoWTEEpOjbYy-7JwEt2_FHVpx1Ir71Yq7JdPz--ilpVX9sfyugQB9AJBG0zqWv2__J_YOndObEw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2170788906</pqid></control><display><type>article</type><title>Mutated SON putatively causes a cancer syndrome comprising high-risk medulloblastoma combined with café-au-lait spots</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Chiu, Celine ; Loth, Stefanie ; Kuhlen, Michaela ; Ginzel, Sebastian ; Schaper, Jörg ; Rosenbaum, Thorsten ; Pietsch, Torsten ; Borkhardt, Arndt ; Hoell, Jessica I.</creator><creatorcontrib>Chiu, Celine ; Loth, Stefanie ; Kuhlen, Michaela ; Ginzel, Sebastian ; Schaper, Jörg ; Rosenbaum, Thorsten ; Pietsch, Torsten ; Borkhardt, Arndt ; Hoell, Jessica I.</creatorcontrib><description>Medulloblastoma is the most frequent malignant brain tumor in childhood. This highly malignant neoplasm occurs usually before 10 years of age and more frequently in boys. The 5-year event-free survival rate for high-risk medulloblastoma is low at 62% despite a multimodal therapy including surgical resection, radiation therapy and chemotherapy. We report the case of a boy, who was born to consanguineous parents. Prominently, he had multiple café-au-lait spots. At the age of 3 years he was diagnosed with a high-risk metastatic medulloblastoma. The patient died only 11 months after diagnosis of a fulminant relapse presenting as meningeal and spinal dissemination. Whole-exome sequencing of germline DNA was employed to detect the underlying mutation for this putative cancer syndrome presenting with the combination of medulloblastoma and skin alterations. After screening all possible homozygous gene SNVs, we identified a mutation of
SON
, an essential protein in cell cycle regulation and cell proliferation, as the most likely genetic cause.</description><identifier>ISSN: 1389-9600</identifier><identifier>EISSN: 1573-7292</identifier><identifier>DOI: 10.1007/s10689-019-00121-z</identifier><identifier>PMID: 30680470</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Brain cancer ; Brain tumors ; Cafe-au-Lait Spots - genetics ; Cancer ; Cancer Research ; Cell cycle ; Cell proliferation ; Cerebellar Neoplasms - genetics ; Chemotherapy ; Child, Preschool ; Children ; Consanguinity ; Deoxyribonucleic acid ; DNA ; DNA sequencing ; DNA-Binding Proteins - genetics ; Epidemiology ; Fatal Outcome ; Human Genetics ; Humans ; Male ; Medulloblastoma ; Medulloblastoma - genetics ; Metastases ; Minor Histocompatibility Antigens - genetics ; Mutation ; Pedigree ; Point Mutation ; Radiation therapy ; Short Communication ; Skin ; Syndrome</subject><ispartof>Familial cancer, 2019-07, Vol.18 (3), p.353-358</ispartof><rights>Springer Nature B.V. 2019</rights><rights>Familial Cancer is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-29ca982cab57b685d3c833c12cff170ecdfdf077b84fde46b7e8a03fe15802a73</citedby><cites>FETCH-LOGICAL-c375t-29ca982cab57b685d3c833c12cff170ecdfdf077b84fde46b7e8a03fe15802a73</cites><orcidid>0000-0002-5532-9845</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10689-019-00121-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10689-019-00121-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30680470$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chiu, Celine</creatorcontrib><creatorcontrib>Loth, Stefanie</creatorcontrib><creatorcontrib>Kuhlen, Michaela</creatorcontrib><creatorcontrib>Ginzel, Sebastian</creatorcontrib><creatorcontrib>Schaper, Jörg</creatorcontrib><creatorcontrib>Rosenbaum, Thorsten</creatorcontrib><creatorcontrib>Pietsch, Torsten</creatorcontrib><creatorcontrib>Borkhardt, Arndt</creatorcontrib><creatorcontrib>Hoell, Jessica I.</creatorcontrib><title>Mutated SON putatively causes a cancer syndrome comprising high-risk medulloblastoma combined with café-au-lait spots</title><title>Familial cancer</title><addtitle>Familial Cancer</addtitle><addtitle>Fam Cancer</addtitle><description>Medulloblastoma is the most frequent malignant brain tumor in childhood. This highly malignant neoplasm occurs usually before 10 years of age and more frequently in boys. The 5-year event-free survival rate for high-risk medulloblastoma is low at 62% despite a multimodal therapy including surgical resection, radiation therapy and chemotherapy. We report the case of a boy, who was born to consanguineous parents. Prominently, he had multiple café-au-lait spots. At the age of 3 years he was diagnosed with a high-risk metastatic medulloblastoma. The patient died only 11 months after diagnosis of a fulminant relapse presenting as meningeal and spinal dissemination. Whole-exome sequencing of germline DNA was employed to detect the underlying mutation for this putative cancer syndrome presenting with the combination of medulloblastoma and skin alterations. After screening all possible homozygous gene SNVs, we identified a mutation of
SON
, an essential protein in cell cycle regulation and cell proliferation, as the most likely genetic cause.</description><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brain cancer</subject><subject>Brain tumors</subject><subject>Cafe-au-Lait Spots - genetics</subject><subject>Cancer</subject><subject>Cancer Research</subject><subject>Cell cycle</subject><subject>Cell proliferation</subject><subject>Cerebellar Neoplasms - genetics</subject><subject>Chemotherapy</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Consanguinity</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA sequencing</subject><subject>DNA-Binding Proteins - genetics</subject><subject>Epidemiology</subject><subject>Fatal Outcome</subject><subject>Human Genetics</subject><subject>Humans</subject><subject>Male</subject><subject>Medulloblastoma</subject><subject>Medulloblastoma - genetics</subject><subject>Metastases</subject><subject>Minor Histocompatibility Antigens - genetics</subject><subject>Mutation</subject><subject>Pedigree</subject><subject>Point Mutation</subject><subject>Radiation therapy</subject><subject>Short Communication</subject><subject>Skin</subject><subject>Syndrome</subject><issn>1389-9600</issn><issn>1573-7292</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kc1u1DAUhS0Eoj_wAiyQJTZsDNf2JHaWqAKKVNoFsLYcx55JSeLBNymavhHPwYv1DlNAYsHC8pHud46texh7JuGVBDCvUUJtGwGSDkglxe0Ddiwro4VRjXpIWtO4qQGO2AniNYACpc1jdqTJCCsDx-zm4zL7OXb809Ul3-51fxOHHQ9-wYjck5hCLBx3U1fyGHnI47b02E9rvunXG0H6Kx9jtwxDbgePcx79Hmr7iVK_9_OGItLPH8IvYvD9zHGbZ3zCHiU_YHx6f5-yL-_efj47FxdX7z-cvbkQQZtqFqoJvrEq-LYybW2rTgerdZAqpCQNxNClLoExrV2lLq7q1kTrQacoKwvKG33KXh5ytyV_WyLObuwxxGHwU8wLOiVNs1LaKkvoi3_Q67yUiX63p8BY20BNlDpQoWTEEpOjbYy-7JwEt2_FHVpx1Ir71Yq7JdPz--ilpVX9sfyugQB9AJBG0zqWv2__J_YOndObEw</recordid><startdate>20190701</startdate><enddate>20190701</enddate><creator>Chiu, Celine</creator><creator>Loth, Stefanie</creator><creator>Kuhlen, Michaela</creator><creator>Ginzel, Sebastian</creator><creator>Schaper, Jörg</creator><creator>Rosenbaum, Thorsten</creator><creator>Pietsch, Torsten</creator><creator>Borkhardt, Arndt</creator><creator>Hoell, Jessica I.</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5532-9845</orcidid></search><sort><creationdate>20190701</creationdate><title>Mutated SON putatively causes a cancer syndrome comprising high-risk medulloblastoma combined with café-au-lait spots</title><author>Chiu, Celine ; Loth, Stefanie ; Kuhlen, Michaela ; Ginzel, Sebastian ; Schaper, Jörg ; Rosenbaum, Thorsten ; Pietsch, Torsten ; Borkhardt, Arndt ; Hoell, Jessica I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-29ca982cab57b685d3c833c12cff170ecdfdf077b84fde46b7e8a03fe15802a73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brain cancer</topic><topic>Brain tumors</topic><topic>Cafe-au-Lait Spots - genetics</topic><topic>Cancer</topic><topic>Cancer Research</topic><topic>Cell cycle</topic><topic>Cell proliferation</topic><topic>Cerebellar Neoplasms - genetics</topic><topic>Chemotherapy</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Consanguinity</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA sequencing</topic><topic>DNA-Binding Proteins - genetics</topic><topic>Epidemiology</topic><topic>Fatal Outcome</topic><topic>Human Genetics</topic><topic>Humans</topic><topic>Male</topic><topic>Medulloblastoma</topic><topic>Medulloblastoma - genetics</topic><topic>Metastases</topic><topic>Minor Histocompatibility Antigens - genetics</topic><topic>Mutation</topic><topic>Pedigree</topic><topic>Point Mutation</topic><topic>Radiation therapy</topic><topic>Short Communication</topic><topic>Skin</topic><topic>Syndrome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chiu, Celine</creatorcontrib><creatorcontrib>Loth, Stefanie</creatorcontrib><creatorcontrib>Kuhlen, Michaela</creatorcontrib><creatorcontrib>Ginzel, Sebastian</creatorcontrib><creatorcontrib>Schaper, Jörg</creatorcontrib><creatorcontrib>Rosenbaum, Thorsten</creatorcontrib><creatorcontrib>Pietsch, Torsten</creatorcontrib><creatorcontrib>Borkhardt, Arndt</creatorcontrib><creatorcontrib>Hoell, Jessica I.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Familial cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chiu, Celine</au><au>Loth, Stefanie</au><au>Kuhlen, Michaela</au><au>Ginzel, Sebastian</au><au>Schaper, Jörg</au><au>Rosenbaum, Thorsten</au><au>Pietsch, Torsten</au><au>Borkhardt, Arndt</au><au>Hoell, Jessica I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mutated SON putatively causes a cancer syndrome comprising high-risk medulloblastoma combined with café-au-lait spots</atitle><jtitle>Familial cancer</jtitle><stitle>Familial Cancer</stitle><addtitle>Fam Cancer</addtitle><date>2019-07-01</date><risdate>2019</risdate><volume>18</volume><issue>3</issue><spage>353</spage><epage>358</epage><pages>353-358</pages><issn>1389-9600</issn><eissn>1573-7292</eissn><abstract>Medulloblastoma is the most frequent malignant brain tumor in childhood. This highly malignant neoplasm occurs usually before 10 years of age and more frequently in boys. The 5-year event-free survival rate for high-risk medulloblastoma is low at 62% despite a multimodal therapy including surgical resection, radiation therapy and chemotherapy. We report the case of a boy, who was born to consanguineous parents. Prominently, he had multiple café-au-lait spots. At the age of 3 years he was diagnosed with a high-risk metastatic medulloblastoma. The patient died only 11 months after diagnosis of a fulminant relapse presenting as meningeal and spinal dissemination. Whole-exome sequencing of germline DNA was employed to detect the underlying mutation for this putative cancer syndrome presenting with the combination of medulloblastoma and skin alterations. After screening all possible homozygous gene SNVs, we identified a mutation of
SON
, an essential protein in cell cycle regulation and cell proliferation, as the most likely genetic cause.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>30680470</pmid><doi>10.1007/s10689-019-00121-z</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-5532-9845</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1389-9600 |
ispartof | Familial cancer, 2019-07, Vol.18 (3), p.353-358 |
issn | 1389-9600 1573-7292 |
language | eng |
recordid | cdi_proquest_miscellaneous_2179423828 |
source | MEDLINE; Springer Nature - Complete Springer Journals |
subjects | Biomedical and Life Sciences Biomedicine Brain cancer Brain tumors Cafe-au-Lait Spots - genetics Cancer Cancer Research Cell cycle Cell proliferation Cerebellar Neoplasms - genetics Chemotherapy Child, Preschool Children Consanguinity Deoxyribonucleic acid DNA DNA sequencing DNA-Binding Proteins - genetics Epidemiology Fatal Outcome Human Genetics Humans Male Medulloblastoma Medulloblastoma - genetics Metastases Minor Histocompatibility Antigens - genetics Mutation Pedigree Point Mutation Radiation therapy Short Communication Skin Syndrome |
title | Mutated SON putatively causes a cancer syndrome comprising high-risk medulloblastoma combined with café-au-lait spots |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T20%3A54%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mutated%20SON%20putatively%20causes%20a%20cancer%20syndrome%20comprising%20high-risk%20medulloblastoma%20combined%20with%20caf%C3%A9-au-lait%20spots&rft.jtitle=Familial%20cancer&rft.au=Chiu,%20Celine&rft.date=2019-07-01&rft.volume=18&rft.issue=3&rft.spage=353&rft.epage=358&rft.pages=353-358&rft.issn=1389-9600&rft.eissn=1573-7292&rft_id=info:doi/10.1007/s10689-019-00121-z&rft_dat=%3Cproquest_cross%3E2170788906%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2170788906&rft_id=info:pmid/30680470&rfr_iscdi=true |